SKI Expression Suppresses Pathogenic Th17 Cell Response and Mitigates Experimental Autoimmune Encephalomyelitis

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Aug 2

PMID 34335622

Citations 4

Authors

Ping Li

Zengli Guo

Yisong Y Wan

Affiliations

Soon will be listed here.

Abstract

Pathogenic Th17 cells are critically involved in many autoimmune diseases, while non-pathogenic Th17 cells are more immune regulatory. Understanding the mechanisms of the induction and maintenance of pathogenic Th17 cells will benefit the development of therapeutic treatments of related diseases. We have shown that the transforming growth factor-β (TGFβ) induced SKI degradation and dissociation from Smad4 complex is a prerequisite for TGFβ-induced Th17 cell differentiation. However, it is unclear whether and how SKI regulates pathogenic Th17 differentiation, which does not require TGFβ cytokine. Here we showed that SKI expression was downregulated during pathogenic Th17 cell differentiation and the ectopic expression of SKI abrogated the differentiation of pathogenic Th17 cells. Functionally, using a knock-in mouse model, we found ectopic SKI expression specifically in T cells prevented myelin oligodendrocyte glycoprotein peptide (MOG) induced experimental autoimmune encephalomyelitis (EAE), an animal model of human multiple sclerosis. We further revealed that induced SKI expression in already differentiated pathogenic Th17 cells reduced the maintenance of Th17 program and ameliorated EAE in an adoptive T cell transfer model. Therefore, our study provides valuable insights of targeting SKI to modulate pathogenic Th17 cell function and treat Th17-related diseases.

Citing Articles

SKI Regulates Medullary Thymic Epithelial Cell Differentiation to Control Peripheral T Cell Responses in Mice.

Chiu H, Weinstein K, Spath S, Hu A, Varela S, Obata-Ninomiya K J Immunol. 2024; 213(1):52-62.

PMID: 38767415 PMC: 11182718. DOI: 10.4049/jimmunol.2300262.

SENP2 restrains the generation of pathogenic Th17 cells in mouse models of colitis.

Yang T, Chiang M, Chang C, Yang S, Huang S, Liao N Commun Biol. 2023; 6(1):629.

PMID: 37301920 PMC: 10257679. DOI: 10.1038/s42003-023-05009-4.

Intricacies of TGF-β signaling in Treg and Th17 cell biology.

Wang J, Zhao X, Wan Y Cell Mol Immunol. 2023; 20(9):1002-1022.

PMID: 37217798 PMC: 10468540. DOI: 10.1038/s41423-023-01036-7.

Physical Activity and Systemic Lupus Erythematosus Among European Populations: A Two-Sample Mendelian Randomization Study.

Huang S, Tian F, Yang X, Fang S, Fan Y, Bao J Front Genet. 2022; 12:784922.

PMID: 35211151 PMC: 8861300. DOI: 10.3389/fgene.2021.784922.

References

Stockinger B, Omenetti S . The dichotomous nature of T helper 17 cells. Nat Rev Immunol. 2017; 17(9):535-544. DOI: 10.1038/nri.2017.50. View

Jager A, Dardalhon V, Sobel R, Bettelli E, Kuchroo V . Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009; 183(11):7169-77. PMC: 2921715. DOI: 10.4049/jimmunol.0901906. View

Colak S, Ten Dijke P . Targeting TGF-β Signaling in Cancer. Trends Cancer. 2017; 3(1):56-71. DOI: 10.1016/j.trecan.2016.11.008. View

Le Scolan E, Zhu Q, Wang L, Bandyopadhyay A, Javelaud D, Mauviel A . Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation. Cancer Res. 2008; 68(9):3277-85. DOI: 10.1158/0008-5472.CAN-07-6793. View

Sutton C, Brereton C, Keogh B, Mills K, Lavelle E . A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med. 2006; 203(7):1685-91. PMC: 2118338. DOI: 10.1084/jem.20060285. View

Wu B, Zhang G, Guo Z, Wang G, Xu X, Li J . The SKI proto-oncogene restrains the resident CD103CD8 T cell response in viral clearance. Cell Mol Immunol. 2020; 18(10):2410-2421. PMC: 8484360. DOI: 10.1038/s41423-020-0495-7. View

Waite J, Skokos D . Th17 response and inflammatory autoimmune diseases. Int J Inflam. 2012; 2012:819467. PMC: 3249891. DOI: 10.1155/2012/819467. View

Zhang S, Takaku M, Zou L, Gu A, Chou W, Zhang G . Reversing SKI-SMAD4-mediated suppression is essential for T17 cell differentiation. Nature. 2017; 551(7678):105-109. PMC: 5743442. DOI: 10.1038/nature24283. View

Bettelli E, Pagany M, Weiner H, Linington C, Sobel R, Kuchroo V . Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med. 2003; 197(9):1073-81. PMC: 2193967. DOI: 10.1084/jem.20021603. View

10.

Malhotra N, Robertson E, Kang J . SMAD2 is essential for TGF beta-mediated Th17 cell generation. J Biol Chem. 2010; 285(38):29044-8. PMC: 2937934. DOI: 10.1074/jbc.C110.156745. View

11.

Esplugues E, Huber S, Gagliani N, Hauser A, Town T, Wan Y . Control of TH17 cells occurs in the small intestine. Nature. 2011; 475(7357):514-8. PMC: 3148838. DOI: 10.1038/nature10228. View

12.

Wu B, Zhang S, Guo Z, Bi Y, Zhou M, Li P . The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 2021; 54(2):308-323.e6. PMC: 7878438. DOI: 10.1016/j.immuni.2020.12.010. View

13.

Ghoreschi K, Laurence A, Yang X, Tato C, McGeachy M, Konkel J . Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature. 2010; 467(7318):967-71. PMC: 3108066. DOI: 10.1038/nature09447. View

14.

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

15.

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

16.

Akhurst R . Targeting TGF-β Signaling for Therapeutic Gain. Cold Spring Harb Perspect Biol. 2017; 9(10). PMC: 5630004. DOI: 10.1101/cshperspect.a022301. View

17.

Chen W, Ten Dijke P . Immunoregulation by members of the TGFβ superfamily. Nat Rev Immunol. 2016; 16(12):723-740. DOI: 10.1038/nri.2016.112. View

18.

Langrish C, Chen Y, Blumenschein W, Mattson J, Basham B, Sedgwick J . IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201(2):233-40. PMC: 2212798. DOI: 10.1084/jem.20041257. View

19.

Ghoreschi K, Laurence A, Yang X, Hirahara K, OShea J . T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 2011; 32(9):395-401. PMC: 3163735. DOI: 10.1016/j.it.2011.06.007. View

20.

Gold R, Linington C, Lassmann H . Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain. 2006; 129(Pt 8):1953-71. DOI: 10.1093/brain/awl075. View